Clal Biotechnology Industries (XTAE:CBI) Net Issuance of Preferred Stock : ₪0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Clal Biotechnology Industries's net issuance of preferred for the six months ended in Dec. 2024 was ₪0.00 Mil. The number is 0, which means that Clal Biotechnology Industries has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Clal Biotechnology Industries's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2024 was ₪0.00 Mil.

Clal Biotechnology Industries Net Issuance of Preferred Stock Historical Data

The historical data trend for Clal Biotechnology Industries's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Net Issuance of Preferred Stock Chart

Clal Biotechnology Industries Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Clal Biotechnology Industries Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Clal Biotechnology Industries Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪0.00 Mil.

Clal Biotechnology Industries Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Clal Biotechnology Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023

Website

http://www.cbi.co.il

Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.